ArticleAdmissibility Of Stem Cell Therapy - Case Law Update AustriaThe question arose in the context of (administrative) criminal proceedings against a doctor. AustriaFood, Drugs, Healthcare, Life SciencesSchoenherr (Schönherr Rechtsanwälte)
ArticleYour Web Doctor Will See You Now - Software As A Medical DevicePatients nowadays have access to an enormous range of medical knowledge through social media, websites and health apps.European UnionFood, Drugs, Healthcare, Life SciencesSchoenherr (Schönherr Rechtsanwälte)
ArticleHealthcare Update - Mastering New Trends: Teleradiology*Technology and innovation are key drivers of advancement in a variety of industries, and certainly in healthcare. The level of patient care can be improved considerably with the right mix...AustriaFood, Drugs, Healthcare, Life SciencesSchoenherr (Schönherr Rechtsanwälte)
ArticleHappy New Regulation: The New Health Technology Assessment Regulation Kicks Off In Early 2025Health technologies, such as pharmaceuticals, medical devices and in-vitro diagnostics, play a key role in the success and progress of our healthcare system.European UnionFood, Drugs, Healthcare, Life SciencesSchoenherr (Schönherr Rechtsanwälte)
ArticleLeucopenia Medicine And Reimbursement CodeThe financing of the Austrian healthcare system by the social security institutions differs between the inpatient and the outpatient sector: AustriaFood, Drugs, Healthcare, Life SciencesPreslmayr Rechtsanwälte OG
ArticleThe End Of A Dry Spell – NIS 2 PublishedAfter several delays, the revision of the NIS Directive was published in the Official Journal of the European Union on 27 December 2022 in the form of Directive (EU) 2022/2555 ("NIS 2").European UnionTechnologySchoenherr (Schönherr Rechtsanwälte)
ArticleRevitalising Healthcare: Austria's New Healthcare ReformAustria's healthcare system got a long-anticipated makeover. After years of small-scale adjustments, a collective amendment – the "Vereinbarungsumsetzungsgesetz 2024"...AustriaFood, Drugs, Healthcare, Life SciencesSchoenherr (Schönherr Rechtsanwälte)
ArticleGold Rush With DisinfectantsUnbelievable but true – due to the outbreak of COVID-19, hand and surface disinfectants are currently hardly available anywhere in the shops. AustriaFood, Drugs, Healthcare, Life SciencesSchoenherr (Schönherr Rechtsanwälte)
ArticleMedical Devices In CEE & SEE: Navigating The Challenges To Modern HealthcareThe list of entities subject to monitoring and certain reporting obligations in Austria extends beyond the provisions of the MDR and the IVDR. It includes persons and entities that use medical devices...AustriaFood, Drugs, Healthcare, Life SciencesWolf Theiss
ArticleGenome Editing - CRISPR/Cas9Genome editing designates new methods that allow targeted interventions to be carried out in the genetic material, the genome of a cell (1). AustriaFood, Drugs, Healthcare, Life SciencesSchoenherr (Schönherr Rechtsanwälte)
ArticleBlood, Tissue, Cells And More – New EU Regulation On Substances Of Human OriginIn Austria, almost 1,000 units of stored blood are needed every day; in Germany, it is around 15,000 units.European UnionFood, Drugs, Healthcare, Life SciencesSchoenherr (Schönherr Rechtsanwälte)
ArticleDRInsider - April 2018Welcome to the 10th edition of the DRInsider, the quarterly Newsletter of the Wolf Theiss Dispute Resolution Group. We provide an overview of recent developments in CEE/SEE and some very interesting case law. GlobalLitigation, Mediation & ArbitrationWolf Theiss